Project Grant HT94252510082
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$964K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
The University of California, Los Angeles (UCLA) was awarded a $662,086 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2022 to April 30, 2025 to investigate NUDT5 as a novel target for ovarian cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goal of transforming health care for...
The University of California, Los Angeles (UCLA) has been awarded a $626,081 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The grant, titled "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance," will support advanced biomedical research to transform healthcare for military service members and the broader public. The research...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $630,000.00 to the University of California, Los Angeles (UCLA) for intravesical nectin4 chimeric antigen receptor T cell therapy research for non-muscle invasive bladder cancer. The award period runs from September 1, 2024 to August 31, 2026. As the prime awardee, UCLA will leverage its facilities, faculty expertise, and administrative capabilities...
The University of California, San Francisco will receive $3.23 million over four years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research combining immunotherapy and synthetic lethality targeting for metastatic breast cancer. Through this award made on September 15, 2021, the University aims to investigate medical solutions for metastatic breast cancer on the battlefield and transform...
The Defense Health Agency awarded a $468,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research developing new therapeutic strategies to target TROP2 in aggressive prostate cancer. The two-year award beginning March 15, 2023 will fund research efforts to investigate medical solutions for prostate cancer on the battlefield and transform health care for service members and the public...
The Department of the Army Medical Command awarded a $1,559,475 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support integrated meta-analysis of prostate cancer genomes from April 15, 2022 to April 15, 2025. Through the grant funding, UCLA will conduct research to transform health care for service members and the public by investigating medical solutions for the battlefield....
This $871,016 Project Grant awarded on January 1, 2024 by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the Beckman Research Institute of the City of Hope supports research on a highly tumor-specific oncolytic virus combined with a viral protein-target T cell engager for the treatment of triple-negative breast cancer. The grant aims to develop innovative therapies for this aggressive form of breast cancer that impacts military personnel and veterans. As a...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $472,500.00 to the University of California, Los Angeles (UCLA) to conduct research on targeting TROP2-mediated ferroptosis as a new therapy for advanced prostate cancer. The research will take place from May 1, 2025 to April 30, 2027 at UCLA's facilities in Los Angeles, CA. As a leading research institution, UCLA will leverage its...
The Defense Health Agency has awarded a $893,000 Project Grant to the University of California, Los Angeles (UCLA) - Office of Research Administration to conduct research under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, effective August 15, 2023 through August 14, 2027, will support UCLA's efforts to investigate the EGFR signaling network in glioblastoma, an aggressive form of brain cancer. As the prime grantee, UCLA will leverage its research...
The University of California, Los Angeles (UCLA) was awarded a $961,089 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research targeting mitochondrial defects in kidney cancer from September 1, 2022 to August 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...